SP1 is a potent transactivator of the IGF1R gene, whereas several tumor suppressors, including breast cancer gene 1 (BRCA1), P53, and Wilms’ tumor protein 1 (WT1), repress the activity of SP1 (Werner & Sarfstein, 2014). This evidence concerns the gene BRCA1 and neoplasm.